Screener / SEC EDGAR /CIK 0001515673 /10-K filed Feb 18, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Ultragenyx Pharmaceutical Inc. RARE

Compare with peers Embed
Filings with the SEC since Jul 20, 2015

1,000 filings, 7 in the last 30 days

SEC filing index

What the 8-Ks said

2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.

CEO, CFO, COO or CAO: 0 (item 5.02)Auditor change: 0 (item 4.01)Not to be relied on: 0 (item 4.02)Cybersecurity: 0 (item 1.05)Restructuring: 2 (item 2.05)Listing notice: 0 (item 3.01)Impairment: 0 (item 2.06)Debt trigger: 0 (item 2.04)
  • Nov 3, 2026 RestructuringReported exit or disposal costs from a restructuring “Costs Associated with Exit or Disposal Activities. On November 3, 2026, the Company announced a restructuring plan to reduce expenses (the “Restructuring”). As part of the Restructuring, the Company is implementing a workforce reduction of approximately 20% of its employees (the “RIF”). The Company communicated the RIF on November 3, 2026 and expects the RIF to be substantially completed by the…” 8-K item 2.05 · all documents
  • Feb 12, 2026 RestructuringReported exit or disposal costs from a restructuring “Costs Associated with Exit or Disposal Activities. On February 12, 2026, the Company began implementation of a strategic restructuring plan to reduce expenses (the “Restructuring”). As part of the Restructuring, the Company is implementing a 10% workforce reduction of approximately 130 employees across the Company (the “RIF”). The Company began notifying affected employees on February 12, 2026,…” 8-K item 2.05 · all documents

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.

Late filings, 8-K notices and going concern

None found in the last 2 years

All checks
  • Late filing notices (NT 10-K, NT 10-Q)
    No notice in the last 2 years.
  • 8-K notices: listing, impairment, debt trigger
    No item 3.01, 2.06 or 2.04 in the last 2 years.
  • Going-concern language in the 10-K
    No statement of substantial doubt in the latest 10-K.

Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.

Every filing on one line

Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)Planned insider sale (Form 144, 10b5-1)
All 77 events

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind · each form links to sec.gov

FiledFormWhat it is
Nov 13, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Nov 4, 2026 10-Q Quarterly report
Nov 3, 2026 8-K Acquisition or sale of assets completed, Quarterly results, Restructuring or exit costs
Oct 30, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Oct 20, 2026 SCHEDULE 13G 5%+ owner (passive)
Oct 19, 2026 4 Insider trade
Oct 19, 2026 8-K Other events
Oct 14, 2026 8-K Material agreement signed
Oct 7, 2026 8-K Material agreement signed
Sep 17, 2026 8-K Other events
Sep 15, 2026 144 Notice of planned insider sale
Sep 15, 2026 4 Insider trade
Sep 8, 2026 4 Insider trade
Sep 2, 2026 8-K Other events
Aug 19, 2026 8-K Other events
Aug 14, 2026 SCHEDULE 13G 5%+ owner (passive)
Aug 13, 2026 SCHEDULE 13G 5%+ owner (passive)
Aug 11, 2026 8-K Other events
Aug 5, 2026 10-Q Quarterly report
Aug 4, 2026 8-K Quarterly results
Aug 4, 2026 4 Insider trade
Aug 4, 2026 4 Insider trade
Aug 3, 2026 144 Notice of planned insider sale
Jul 31, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Jul 31, 2026 SCHEDULE 13G 5%+ owner (passive)
Jul 30, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Jul 6, 2026 4 Insider trade
Jul 1, 2026 144 Notice of planned insider sale
Jun 15, 2026 144 Notice of planned insider sale
Jun 15, 2026 144 Notice of planned insider sale
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 12, 2026 S-8 Shares registered for employee plans
Jun 1, 2026 144 Notice of planned insider sale
Jun 1, 2026 4 Insider trade
May 18, 2026 144 Notice of planned insider sale
May 18, 2026 4 Insider trade
May 18, 2026 4 Insider trade
May 18, 2026 4 Insider trade
May 18, 2026 4 Insider trade
May 18, 2026 4 Insider trade
May 18, 2026 4 Insider trade
May 18, 2026 4 Insider trade
May 18, 2026 8-K Director or officer change, Shareholder vote results
May 6, 2026 4 Insider trade
May 6, 2026 10-Q Quarterly report
May 5, 2026 8-K Quarterly results
May 4, 2026 4 Insider trade
May 1, 2026 144 Notice of planned insider sale
Apr 30, 2026 DEFA14A Extra proxy material
Apr 29, 2026 SCHEDULE 13G 5%+ owner (passive)
Apr 24, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 20, 2026 4 Insider trade
Apr 2, 2026 4 Insider trade
Apr 2, 2026 8-K Other events
Apr 1, 2026 144 Notice of planned insider sale
Mar 30, 2026 8-K Other events
Mar 27, 2026 ARS Annual report to shareholders
Mar 27, 2026 DEFA14A Extra proxy material
Mar 27, 2026 DEF 14A Proxy statement
Mar 27, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Mar 12, 2026 8-K Other events
Mar 10, 2026 144 Notice of planned insider sale
Mar 10, 2026 4 Insider trade
Mar 6, 2026 144 Notice of planned insider sale
Mar 3, 2026 144 Notice of planned insider sale
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 2, 2026 144 Notice of planned insider sale
Feb 23, 2026 8-K Other events
Feb 18, 2026 10-K Annual report
Feb 12, 2026 8-K Quarterly results, Restructuring or exit costs
Feb 5, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Feb 3, 2026 4 Insider trade
Feb 3, 2026 8-K Other events
Feb 2, 2026 144 Notice of planned insider sale
Jan 30, 2026 8-K Other events
Jan 12, 2026 8-K Quarterly results
Jan 5, 2026 4 Insider trade
Jan 2, 2026 144 Notice of planned insider sale
Dec 30, 2025 8-K Other events
Dec 30, 2025 4 Insider trade
Dec 29, 2025 8-K Other events
Dec 11, 2025 4 Insider trade
Dec 10, 2025 144 Notice of planned insider sale
Nov 5, 2025 10-Q Quarterly report
Nov 5, 2025 SCHEDULE 13G 5%+ owner (passive)
Nov 4, 2025 8-K Material agreement signed, Quarterly results
Show the other 75 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Sources

SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.

Also

Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RARE/export.csv") into a cell.

Next:Earnings releases
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.